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Abstract 1 
Neisseria meningitidis (the meningococcus) remains an important cause of human disease, 2 
including meningitis and sepsis. Adaptation to the host environment includes many interactions 3 
with specific cell surface receptors, resulting in intracellular signalling and cytoskeletal 4 
rearrangements that contribute to pathogenesis. Here, we assessed the interactions between 5 
meningococci and Fibroblast Growth Factor Receptor 1-IIIc (FGFR1-IIIc): a receptor specific to 6 
endothelial cells of the microvasculature, including that of the blood-brain barrier. We show 7 
that the meningococcus recruits FGFR1-IIIc onto the surface of human blood microvascular 8 
endothelial cells (HBMECs). Furthermore, we demonstrate that expression of FGFR1-IIIc is 9 
required for optimal invasion of HBMECs by meningococci. We show that the ability of 10 
N. meningitidis to interact with the ligand-binding domain of FGFR1-IIIc is shared with the 11 
other pathogenic Neisseria species, N. gonorrhoeae, but not with commensal bacteria including 12 
non-pathogenic Neisseria species. 13 
14 
 
1. Introduction 15 
Neisseria meningitidis, or the meningococcus, while normally a harmless commensal of the 16 
human oropharynx, can occasionally cause devastating disease including meningitis, sepsis, 17 
disseminated intravascular coagulation (DIC) and multiple organ failure [1]. Penetration of the 18 
oropharyngeal epithelial mucosa and entry into the bloodstream by meningococci is a crucial 19 
step in development of systemic disease, while penetration of the blood-brain barrier (BBB) is 20 
a prerequisite for development of meningitis [2, 3]. Attachment to vascular endothelial cells 21 
induces membrane protrusions at meningococcal binding site and leads to formation of specific 22 
protein complexes known as cortical plaques underneath meningococcal colonies [4-7]. The 23 
process by which these steps occur is not fully understood [8-12]. Adhesion to human cells by 24 
meningococci is mediated by the type IV pilus, major adhesins including Opa and Opc [13, 14], 25 
as well as a number of additional adhesins including the porins PorA [15] and PorB [16], and 26 
sialic acid residues on either lipooligosaccharide or the Group B polysaccharide capsule [17]. 27 
While a number of host cell receptors interacting with meningococci including alpha actinin 28 
[18], integrins [8, 19, 20], carcinoembryonic antigen‐related cell adhesion molecules 29 
(CEACAMs) [21, 22], CD46 [23, 24], platelet activating factor receptor [25], laminin receptor 30 
[15], galectin-3 [26], and receptor tyrosine kinases [27, 28], have been identified, no tissue-31 
specific receptors for this pathogen have been identified. 32 
Fibroblast Growth Factor Receptors (FGFRs) are transmembrane proteins that belong to the 33 
Receptor Tyrosine Kinase (RTK) family of signalling molecules [29]. Four members comprise 34 
the family and are responsible for recognising the 22 Fibroblast Growth Factors (FGFs) found 35 
in humans [30-32]. FGFs are involved in cell differentiation, migration and proliferation during 36 
early embryogenesis and play an important role in tissue repair, wound healing [33] and 37 
tumour angiogenesis in adulthood [29, 34, 35]. Splicing of FGFR transcripts generates a variety 38 
of specific isoforms in different cell types and tissues, recognising specific types of FGF 39 
molecules [29, 31, 36, 37]. 40 
FGFRs are single transmembrane receptors; the extracellular N-terminal region consists of 41 
three IgG-like domains that form a ligand-binding domain with an acidic box which interacts 42 
with heparin sulphate proteoglycans (HSPGs) and cell adhesion molecules (CAMs) [38]. This is 43 
followed by a transmembrane region and a C-terminal cytoplasmic region containing 7 specific 44 
tyrosine residues [39-42]. Binding of FGFs to the receptors leads to dimerization of the receptor 45 
and tyrosine autophosphorylation, which in turn activates the receptor, triggering downstream 46 
signalling pathways [43-46]. FGFR1 signalling and expression is important in maintaining the 47 
integrity and differentiation of endothelial cells forming the microvasculature [34, 47, 48]. 48 
Here, we demonstrate specific interaction of FGFRs in human brain microvascular endothelial 49 
cells (HBMECs) with meningococci, and show that this interaction influences the ability of N. 50 
meningitidis to invade these cells.  51 
 
2. Materials and methods 52 
2.1. Bacterial growth and culture 53 
E. coli JM109 cells (Promega) were grown on Lysogeny Broth agar (Oxoid) supplemented 54 
where appropriate with 100 µg/ml ampicillin (Sigma). N. meningitidis serogroup B strain 55 
MC58 (ATCC® BAA335™) [49] and clinical isolates of N. meningitidis from our laboratory 56 
collection, N. gonorrhoeae strain FA1090 (ATCC 700825), N. lactamica strain ATCC23970, 57 
N. polysaccharea (a clinical isolate from laboratory stocks), H. influenzae Rd KW20 (ATCC 58 
51097) [50], and S. pneumoniae T4 (unencapsulated) [51] were routinely cultured on 59 
chocolated horse blood agar (Chocolate agar, Oxoid) at 37°C, in an atmosphere of air plus 60 
5% CO2. 61 
2.2. Cell association assay and cell invasion (Gentamicin protection) assay 62 
To quantify cell association and cell invasion of HBMECs with N. meningitidis HBMECs were 63 
seeded and grown overnight or for 48 h after siRNA transfection until 100% confluent in 24-64 
well plates. Cells were infected with 1×107 CFU bacteria for 4 h in ECM-b media without any 65 
supplements. Cell association and invasion were then determined as described previously [52]. 66 
2.3. Confocal Immunofluorescent Microscopy 67 
HBMECs were seeded onto fibronectin-coated coverslips (ca. 1 × 105 cells) and grown overnight 68 
to reach a confluency of 70-80%. Cells were infected for 4 h (MOI 200). Coverslips were washed 69 
with PBS and fixed with 4% paraformaldehyde (w/v) in PBS for 5 min. Coverslips were then 70 
washed with PBS and blocked in 4% (w/v) BSA/PBS at 4°C overnight. For intracellular staining, 71 
cells were permeabilised using 0.1% Saponin, 20 mM glycine in 4% BSA/TBS at 4°C. 72 
Subsequent staining procedures were carried out in 4% (w/v) BSA/TBS. Briefly, coverslips 73 
incubated with primary antibody for 1 h were washed with PBS followed by one wash with 74 
dH2O. Coverslips were then incubated with secondary antibody for 1 h in the dark followed by 75 
washes with PBS-Tween (0.05% v/v; PBS-T), PBS and then dH2O. Coverslips were then 76 
mounted on glass slides with ProLong® Gold and SlowFade® Gold Antifade Reagents with DAPI 77 
(Invitrogen). Coverslips were analysed using a Zeiss LSM-700 confocal microscope. Images 78 
were processed with ImageJ, Adobe Photoshop and LSM Image Browser software. 79 
2.4. Antibodies and reagents 80 
Antibodies detecting FGFR1: Flg S-16 (goat polyclonal antibody) and Flg C-15 (mouse 81 
antibody), phosphorylated FGFR1 (p-Y766, mouse monoclonal antibody), Alpha-actinin 82 
(sc-17829) and Rab5 (sc-46692) were purchased from Santa Cruz Biotechnology. Secondary 83 
antibodies conjugated to various fluorochromes, and Phalloidin conjugated to fluorochrome 488 84 
were obtained from Life Technologies-Invitrogen. The antibody detecting 37LRP (A-7) was 85 
 
purchased from Santa Cruz Biotechnology and antibody against 67LR (Mluc-5) was purchased 86 
from Thermo Scientific. 87 
2.5. Cloning and expression of FGFR1 IIIc and Fc-stop 88 
HBMECs grown in fibronectin-coated T75 flasks (BD Bioscience) were harvested by trypsin 89 
treatment and centrifugation for 5 min at 300 × g. Cells were lysed in lysis buffer (SIGMA 90 
GenElute™ Mammalian Total RNA Miniprep Kits) supplemented with 1% (v/v) 2-β-91 
Mercaptoethanol and RNA was extracted according to the manufacturer’s protocol (Sigma 92 
GenElute™ Mammalian Total RNA Miniprep Kit). The concentration of RNA was measured using 93 
a Nanodrop spectrophotometer and adjusted to 200 ng µl-1. DNase treatment was performed 94 
following the manufacturers protocol (Turbo DNase, Life Technologies). 10 µl of RNA was used 95 
for cDNA preparation using the High Capacity cDNA Reverse Transcription kit (Applied 96 
Biosystems). HBMEC cDNA was then used as template to amplify the extracellular domain of 97 
FGFR1 IIIc isoform using primers designed to amplify the extracellular domain of FGFR1 and 98 
containing restriction sites for restriction enzymes NdeI (Forward; 99 
GCGGCTTAATCATATGCAGGGACCCGGATCCATGTGGAGCTGGAAGTGCC) and NotI (Reverse; 100 
GCGCGATTAAGCGGCCGCttaCAGGGGCGAGGTCA). The amplified PCR product was gel purified, 101 
digested and then ligated into NotI and NdeI-digested pEF-Bos-ss-Fc-FGFR2IIIaTM-ires-TPZ 102 
[53-55] using the LigaFast TMRapid DNA Ligation System (Promega). The ligated plasmid was 103 
used for transformation of competent E. coli JM109 cells (Promega). The resulting plasmid was 104 
named pEF-Bos-ss-Fc-extFGFR1IIIc-ires-TPZ. A plasmid expressing LAMR1, which has been 105 
described previously [56], was mutated to introduce a stop codon at the junction of the 106 
sequence encoding Fc and LAMR1, resulting in a plasmid designated pEF-Bos-ss-Fc-Stop-LRP-107 
ires-TPZ encoding the Fc tag (Fc-stop) only. For expression of Fc-tagged FGFR2 IIIa TM, pEF-108 
Bos-ss-Fc-extFGFR1IIIc-ires-TPZ and Fc-tag, 293T cells were grown overnight to 30% 109 
confluence in Dulbecco’s Modified Eagle Medium (DMEM; Gibco) supplemented with FCS 110 
(10%v/v) and transfected by calcium phosphate precipitation. Media was collected 72 h post-111 
transfection and Fc-tagged recombinant proteins were purified on a Protein AIG-Sepharose 112 
(Source BioScience LifeSciences) column. Protein concentration in each fraction was quantified 113 
using the BCA kit following manufacturer’s protocol (Thermo Scientific). 114 
2.6. FGFR1 siRNA transfection in HBMECs 115 
Human FGFR1 siRNA (siGENOME SMART pool) and control scrambled siRNA were obtained from 116 
Dharmachon/Thermo Scientific and reconstituted following the manufacturer guidance. FGFR1 117 
siRNA was resuspended in 1 ml of 1 × siRNA buffer to a final concentration of 50 µM (stock). 118 
HBMECs were seeded into 24-well plates pre-coated with fibronectin, as previously described, 119 
and grown overnight to reach a confluency of 70-80%. Transfection media was prepared by 120 
mixing serum- and antibiotic-free media with siRNA from a 50µM stock to a final concentration 121 
 
of 5µM; in a separate tube Transfection reagent number 1 (Thermo Scientific-Dharmacon) was 122 
added to serum and antibiotic-free media. Both tubes were incubated for 5 min at room 123 
temperature and then mixed together by pipetting and incubated at room temperature for 20-124 
30 min. Cells were washed with serum and antibiotic-free medium and 240 µl of complete 125 
media without antibiotics were added to each well and then the transfection mixture was added 126 
drop-wise to each well to a final concentration of 50 nM siRNA/ well. Cells were then incubated 127 
for 6 h and then the media was replaced with complete media (Endothelial cell medium (ECM-128 
b) (ScienCell) supplemented with ECGS (containing EGF, VEGF) (ScienCell) (1% v/v) and FBS 129 
(5% v/v) and penicillin/streptomycin (ScienCell; 1% v/v). The level of FGFR1 expression was 130 
examined at RNA and protein levels at 24, 48 and 72 h post transfection. 131 
2.7. ELISA 132 
96-well plates (NUNC Immobilizer Amino) were coated with 100 μl of protein A (Pierce; 1 µg 133 
ml-1) in PBS for 1 h, washed once with PBS-T and then 86.5 ×10 -15 M of Fc-tagged recombinant 134 
proteins added to each well in carbonate buffer (pH 9.6). Plates were incubated for 1 h and 135 
then washed three times with PBS-T. Plates were blocked with 1% BSA/PBS (w/v) for 1 h, then 136 
washed once with PBS-T. Bacterial cells harvested from overnight plates and resuspended in 137 
PBS-T, washed with the same buffer three times and finally resuspended in sodium carbonate 138 
buffer (44 mM NaHCO3, 6.0 mM Na2CO3; pH: 9.6). The OD600 was measured and 20 ng (2 µl of 139 
10 ng µl-1) of digoxigenin (DIG; Roche) was added to 1 ml of bacterial suspension with OD600:1. 140 
The bacterial suspensions were incubated for 2 h in the dark at room temperature on the 141 
shaker. Bacteria then were washed three times with PBS-T by centrifugation (13000 × g for 1 142 
minute) and resuspended in 1% BSA/PBS (w/v). OD600 in 1% BSA/PBS was adjusted to 0.02 143 
for ELISA. For each experiment freshly labelled bacterial strains were used. 100 μl of DIG-144 
labelled bacteria were added to each well and plates were incubated at 4°C overnight then 145 
washed five times with PBS-T. 100 µl of anti-DIG-alkaline phosphatase antibody (Roche; 146 
0.0002 v/v) in 1% BSA/PBS was then added to each well and incubated for 1h then washed 147 
three times with PBS-T. 200 µl of alkaline phosphatase substrate (SIGMA) was added and 148 
plates were incubated for 1h. The OD405 was measured for each sample and values obtained 149 
subtracted from the binding of the same DIG-labelled strain to 1% BSA/PBS.  150 
 
3. Results 151 
3.1. N. meningitidis colonies recruit FGFR1 on the apical surface of Human Brain 152 
Microvascular Endothelial Cells (HBMECs). 153 
To study the possible interaction of FGFR1 by meningococcal colonies, HBMECs were infected 154 
with N. meningitidis for 4 h, fixed, and prepared for subsequent investigation by 155 
immunofluorescence microscopy. FGFR1 was recruited by meningococcal colonies on the apical 156 
surface of HBMECs (Figure 1-A). Previously, we have shown that meningococci interact with 157 
both the 67-kDa laminin receptor (67LR) and the 37-kDa laminin receptor precursor (37LRP) 158 
isoforms of the laminin receptor [15, 56]. Here, we show that FGFR1 recruitment to 159 
meningococcal colonies coincided with recruitment of both isoforms of this receptor (Figure 1-160 
A). To address whether FGFR1 recruited by meningococci is activated, HBMECs were labelled 161 
with primary antibodies specific for phosphorylated tyrosine 766 (p-Y766), which is a feature 162 
of the activated form of FGFR1, and with antibodies specific for the two main isoforms of the 163 
laminin receptor, 67LR and 37LRP. In all cases the phosphorylated FGFR1 co-localised with 164 
meningococcal cells (Figure 1-B). Meningococcal colonies co-localised with FGFR1 and 37LRP, 165 
up to 60% of which co-localised with FGFR1. This was significantly higher than co-localisation 166 
of the microcolonies with the 67LR isoform of the laminin receptor (Figure 1-C). 167 
3.2. Internalized N. meningitidis associated with activated FGFR1. 168 
To determine whether internalised bacteria were associated with activated FGFR1, HBMECs 169 
were infected for 4 h with N. meningitidis and non-internalised bacterial cells were killed by 170 
treatment with gentamicin. Immunofluorescent staining for actin (phaloidin) and activated 171 
FGFR1 (p-Y766) confirmed that meningococci recruited activated FGFR1 in the cytoplasm of 172 
HBMECs, and that the receptor was trafficked inside the cells alongside with meningococcal 173 
cells (Figure 2). To confirm that the bacterial cells in gentamycin-treated monolayers were 174 
internalised, a Z-stack image was constructed. Bacterial cells could be observed beneath the 175 
membrane of the endothelial cells (Figure 2-B and 2C). To determine whether the internalised 176 
bacteria were associated with endosomes we probed infected monolayers for Rab5. Internalised 177 
bacteria associated with activated FGFR1 were also co-located with this marker for early 178 
endosomes, indicating that the bacteria were endosome-associated (Figure 2D). 179 
3.3. FGFR1 expression is required for meningococcal invasion into HBMECs. 180 
To determine whether interaction of meningococci with FGFR1 on the surface of HBMECs 181 
was required for internalisation of the bacteria, FGFR1 expression was knocked down in 182 
HBMECs using siRNA treatment. Sixty hours post-siRNA treatment, cells were infected with 183 
meningococci and cell association and invasion assays were performed. The numbers of 184 
meningococcal cells associated with HBMECs was significantly and dramatically reduced in 185 
 
response to FGFR1 knock-down (Figure 3-A). Treatment with scrambled siRNA under the 186 
same conditions did not result in a significant reduction in association of meningococci 187 
with HBMEC cells. There was also a significant decrease in the number of internalised 188 
meningococcal cells recovered from FGFR1 siRNA-transfected HBMECs (Figure 3-B). Again, 189 
treatment with a scrambled siRNA did not significantly affect binding of meningococci to 190 
the HBMEC cells. This demonstrates that FGFR1 expression plays an important and specific 191 
role in meningococcal adhesion to and invasion into HBMECs. 192 
3.4. N. meningitidis interacts specifically with FGFR1 IIIc. 193 
To determine which isoforms of FGFR1 are expressed in HBMEC cells we performed RT-PCR 194 
using cDNA generated from total RNA extracted from HBMECs. Various combinations of primers 195 
specific for exon 7, 8 and 9 for FGFR1, FGFR2 and FGFR3 were used to determine which 196 
isoforms of FGFR were expressed. Amplification products across exons 7 and 9 of FGFR1, 197 
corresponding to FGFR1 IIIc, but not across exons 7 and 8, corresponding to FGFR1 IIIb were 198 
detected, while amplification across exons 7 and 8, corresponding to FGFR3 IIIb, but not across 199 
exons 7 and 9, corresponding to FGFR3 IIIc were amplified. No amplicons were detected across 200 
either exons 7 and 8 or exons 7 and 9 of FGFR2. Thus, FGFR1 IIIc and FGFR3 IIIb isoforms 201 
were both expressed in HBMECs. To determine whether meningococci could interact directly 202 
with the extracellular domain of FGFR1 IIIc this protein was cloned and expressed as an Fc-203 
tagged fusion protein. Two other proteins: Fc-FGFR2 IIIa TM, comprising the trans-membrane 204 
region of FGFR2 IIIa fused to the immunoglobulin Fc domain, and the Fc portion of 205 
immunoglobulin alone (Fc-stop) were used as controls for possible interaction with 206 
N. meningitidis that was not specific for the FGFR1 IIIc extracellular domain. Both control 207 
proteins were derived from clones employing the same vector and purified by the same method 208 
as Fc-FGFR1 IIIc. Each of the purified proteins were employed as an immobilised ligand in 209 
ELISA experiments to assess the ability of DIG-labelled N. meningitidis (MC58) to bind to these 210 
ligands. N. meningitidis (MC58) bound Fc-FGFR1 to a significantly greater degree than either 211 
Fc-FGFR2 IIIa TM or Fc-stop (Figure 4 A). This indicates that the observed interaction of Fc-212 
FGFR1 was not due to meningococci binding to the Fc-tag of the expressed extracellular domain 213 
of FGFR1 and thus demonstrates a direct interaction between the receptor present on the apical 214 
surface of HBMECs and surface structures of N. meningitidis. 215 
3.5. Interaction between N. meningitidis and FGFR1 is common among clinical 216 
isolates of different serogroups and is shared by N. gonorrhoeae but not commensal 217 
Neisseria species, nor other bacterial pathogens targeting the meninges. 218 
Having shown that Fc-FGFR1 IIIc interacts with meningococci, we sought to establish whether 219 
other Neisseria species could interact with this receptor. We tested representative strains 220 
belonging to several Neisseria species, including the human pathogen N. gonorrhoeae and the 221 
normally non-pathogenic species N. polysaccharea and N. lactamica, for interaction with Fc-222 
 
FGFR1 in ELISA assays. N. gonorrhoeae cells bound to wells containing Fc-FGFR1 at similar 223 
levels to N. meningitidis MC58, and to a significantly higher level than to FGFR2. In both cases 224 
N. gonorrhoeae bound to Fc-FGFR1 to a significantly higher degree than either of the two 225 
commensal species, which did not bind to a significantly higher degree to Fc-FGFR1 than to 226 
control wells containing only Fc-FGFR2 TM (Figure 4 B). To determine whether binding of 227 
N. meningitidis to FGFR1 was a phenomenon common to other isolates of N. meningitidis we 228 
tested a panel of N. meningitidis isolates belonging to serogroups A, B, C and X. All strains 229 
were able to bind Fc-FGFR1 specifically at levels similar to the serogroup B strain MC58 (Figure 230 
4 C). We previously showed that, like the meningococcus, the pathogens S. pneumoniae and 231 
H. influenzae, both of which are known to target the meninges, each targeted the laminin 232 
receptor on HBMEC cells as a prerequisite for internalisation [15]. Neither representative S. 233 
pneumoniae nor H. influenzae strains bound significantly to Fc-FGFR1 (Figure 4 D), 234 
demonstrating that the observed interaction between the pathogenic Neisseria species was 235 
specific.  236 
 
4. Discussion 237 
The interactions between meningococci and the BBB are central to the ability of this pathogen 238 
to cause meningitis, but they are complex and incompletely understood. Meningococci have 239 
been shown to interact with brain microvascular endothelial cells (BMECs) through various 240 
molecules of both the bacterium and the endothelial cell and several of these interactions result 241 
in disruption of the BBB and favour bacterial entry into the cerebro-spinal fluid. Type IV pili, 242 
for example, initiate initial binding to human brain endothelial cells via the pilin molecules PilQ, 243 
PilE and PilV, which bind to host laminin receptor [15], CD147 and β-adrenergic receptor [57], 244 
respectively. The latter receptor acts as a mechano-sensor, signalling via the β2-245 
adrenoceptor/β-arrestin pathway and recruits Src tyrosine kinase and junctional complex 246 
proteins to the site of bacterial attachment [57, 58]. Pilus-mediated meningococcal attachment 247 
to BMECs results in recruitment of adherens junction complex components (VE-cadherin, p120-248 
catenin, β-catenin), tight junction components (ZO1, ZO2 and caludin-5), and the 249 
Par3/Par6/PKCz polarity complex to the site of bacterial attachment. This results in disruption 250 
of adherens junctions and tight junctions and the opening of the paracellular pathway [59]. 251 
Meningococci also interact with BMECs indirectly via the major adhesin Opc, which binds 252 
fibronectin and thus allows the bacterium to interact with the integrin α-5 β-1-receptor on the 253 
endothelial cell surface [60]. Opc/integrin-mediated interaction of endothelial cells with 254 
meningococci results in activation and phosphorylation of JNK1 and JNK2, as well as their 255 
substrates c-Jun, resulting JNK1 and JNK2-dependent invasion [8]. Meningococci also activate 256 
p38 MAPK, but this interaction is independent of the Opc/integrin interaction, and results in the 257 
induction of the inflammatory cytokines IL-6 and IL-8 [8]. Attachment of meningococci to 258 
endothelial cells also initiates secretion of host matrix metalloproteinase-8, which results in 259 
cleavage of the tight junction component occludin, which in turn leads to increased paracellular 260 
permeability [61]. 261 
A number of receptor tyrosine kinases have been shown to be important for the interaction 262 
between BMECs and meningococci. Several activated RTKs including the EebB family receptors 263 
epidermal growth factor receptor (EGFR), ErbB2 and ErbB4 were shown to be activated in 264 
endothelial cells after interaction with meningococci [27]. A requirement for Focal Adhesion 265 
Kinases and activation of Src in the internalization of meningococci via interaction with integrins 266 
has also been demonstrated [20]. Considering the role of FGFR1 in maintaining the integrity of 267 
the BBB and angiogenesis [62], we examined the possible role of FGFR1 in interactions with 268 
meningococci. HBMECs infected with meningococci were shown to recruit FGFR1 to their apical 269 
surface. Recently, we showed that meningococci bind to both 37LRP and Galectin-3 on the 270 
surface of HBMECs [56]. Here, we showed that FGFR1 recruitment coincided with recruitment 271 
of both isoforms (37LRP and 67LR) of the laminin receptor; molecules already implicated in 272 
N. meningitidis-HBMEC interactions [15]. Ligation of the extracellular domain of FGFRs by their 273 
 
ligands leads to auto-phosphorylation of tyrosine residues in the cytoplasmic domain of the 274 
receptor; these phosphorylated residues subsequently serve as docking sites for a number of 275 
adaptor proteins responsible for regulation of various downstream signalling cascades [31]. 276 
The FGFR1 molecules recruited by meningococci were shown to be activated and activated 277 
receptors and meningococcal cells also co-localised with α-actinin. The microcolonies were also 278 
associated with the early endosomal marker Rab5, confirming that the bacteria were entering 279 
the endosomal pathway. This is in agreement with previous studies on the trafficking of FGFR1 280 
into early endosomes inside the cytoplasm, and the regulation of its trafficking by Syndecan 4 281 
in a clathrin-independent manner [63]. We also demonstrated by confocal microscopy in 282 
HBMECs treated with gentamicin that the receptor is internalised into the cytoplasm along with 283 
invading meningococci. To determine whether FGFR1 was required for meningococcal-HBMECs 284 
interactions, FGFR1 expression was transiently inhibited by using FGFR1 siRNA transfection. 285 
FGFR1 knock-down in HBMECs resulted in a dramatic reduction in both association and 286 
internalisation of meningococci into HBMECs. Surprisingly, the residual levels of both cellular 287 
association and invasion were very low as we would have expected there to be interaction via 288 
the other known receptors for the pathogen. Our data confirm that direct interaction between 289 
the extracellular domain of FGFR1 and meningococci is required for consequent activation of 290 
the receptor and internalisation of bacteria into the HBMECs. 291 
The mechanisms by which recruitment of FGFR1 by meningococcal colonies leads to their 292 
internalisation is unknown. Interaction of meningococci with HBMECs has previously been 293 
shown to lead to higher levels of activation of ERK 1, 2 due to activation of ErbB2 in these cells 294 
[28]. However, levels of ERK 1,2 activation in cells in which FGFR1 was knocked down by siRNA 295 
transfection were unaffected, demonstrating that FGFR1 does not regulate the levels of ERK1, 296 
2 activation [64]. Several studies on meningococcal infection of endothelial cells showed that 297 
invasion of bacteria requires activation of Src, phosphorylation of cortactin via the Src pathway 298 
and activation of focal adhesion kinases (FAKs) [20, 28, 65]. Also, it has been shown that 299 
meningococcal cells hijack the β-arrestin/β 2-adrenoreceptor pathway to invade endothelial 300 
cells and cross the BBB: inhibition of β-arrestin mediated activation of Src, prevents the 301 
invasion of meningococcal cells [58]. Src is required for cortactin phosphorylation by FGF1 302 
which can provide an alternate downstream pathway of FGFR1 from PLCγ and can be involved 303 
in cytoskeletal rearrangement [66, 67]. However it was reported that mutation of Y766 in 304 
FGFR1 leads to higher level activations of PLCγ which inhibits Src activation [68]. These 305 
observations suggest that FGFR1 siRNA transfection of HBMECs may have led to the same 306 
effect on inhibition of Src activation which consequently inhibited meningococcal invasion into 307 
HBMECs. This effect appears to be specific to the meningococcus as the bacterial pathogens H. 308 
influenzae and S. pneumoniae, which also cross the BBB and can cause meningitis, do not 309 
interact with FGFR1 IIIc on the surface of HBMECs. On the other hand, N. gonorrhoeae, which 310 
 
does not usually interact with the BBB is also able to interact with FGFR1 IIIc to the same 311 
extent as N. meningitidis. 312 
Although the specific role of FGFRs in infectious diseases has not been excessively investigated, 313 
an increase in FGF2 expression enhances Chlamydia trachomatis binding and internalisation 314 
into epithelial cells [69]. C. trachomatis facilitates entry by binding directly to FGF2, which 315 
results in binding of FGF2-bacteria-heperan sulfate proteoglycan (HSPG) complexes to FGFR 316 
and internalisation of the elementary bodies of these bacteria into the cells. More recently, 317 
HSPG-associated FGFR1 has been implicated in internalisation of Rickettsia rickettsii into 318 
cultured human microvascular endothelial cells and inhibition of FGFR1 in a R. conorii murine 319 
model of endothelial-target spotted fever rickettsiosis; reduced the rickettsial burden in 320 
infected mice [70]. 321 
Interaction of meningococci and FGFR1 in BMECs occurs within a complex network of 322 
interactions. The various pathways are likely to be both synergistic and antagonistic. FGFR1 323 
engagement by basic fibroblast growth factor receptor has recently been shown to protect the 324 
integrity of HBMEC monolayers preventing the downregulation of the junction proteins ZO-1, 325 
occludin and VE-cadherin in response to oxygen-glucose deprivation and deoxygenation [71]. 326 
This is in contrast to the known effects of meningococcal interactions on these molecules. Thus, 327 
engagement of FGFR1 may favour a trans-cellular pathway through HBMECs rather than a 328 
para-cellular pathway in which the integrity of the monolayer would have to be compromised. 329 
Further investigations are required to identify and unravel the role of FGFR1 signalling in 330 
meningococcal invasion into HBMECs and other type of endothelial cells forming the 331 
microvasculature in other organs.  332 
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Figure Legends 341 
Figure 1. Activated FGFR1 is recruited by meningococcal colonies. (A) HBMECs were 342 
infected with meningococcal cells (MOI: 200) for 4 h. Neisseria meningitidis colonies were 343 
visualized with DAPI (blue), FGFR1 was probed with anti-FGFR1 primary antibody and detected 344 
with anti-goat Alexa Fluor 680 antibody (red). 37LRP and 67LR were probed with primary 345 
antibodies and detected with anti-mouse Alexa Fluor 488 antibodies (green). FGFR1 was 346 
recruited by meningococcal colonies, which coincides with recruitment of 37LRP and, to a less 347 
extent, 67LR. Co-localizations area is shown by arrows (images are representative of 10 348 
infected cells). (B) FGFR1 phosphorylated at Tyrosine 766 (p-Y766) was labelled with Alexa 349 
Fluor 680 (red) and both isoforms of Laminin receptor (67LR and 37LRP) with Alexa Fluor 488 350 
(green). Recruitment of activated FGFR1 (p-Y766) coincided with recruitment of 37LRP and, to 351 
a less extent, 67LR. (C) Levels of co-localization of MC58 with 37LRP, 67LR and p-Y766 352 
(activated FGFR1) were quantified by measuring the percentage of co-localization of each 353 
receptor with MC58 in 30 fields. There was a significant difference between recruitment by 354 
MC58 of activated FGFR1 or 37LRP with recruitment of 67LR (p= 0.04, One Way ANOVA, 355 
multiple comparison, Dunn’s Test). 356 
Figure 2. Activated FGFR1 is recruited by internalised meningococci within HBMECs. 357 
(A) In infected HBMECs α-actinin and actin were labelled with Alexa Fluor 680 (Red) and the 358 
activated form of FGFR1 labelled with Alexa Fluor 488 (Green). Bacteria were labelled with DAPI 359 
(Blue). Internalized bacteria co-localized with both α-actinin (sc-17829), actin (phaloidin) and 360 
activated FGFR1 (p-Y766) (arrowheads). (B) Z-stack image of meningococcal colonies shows 361 
that internalized bacteria (co-localizing with α-actinin) recruit activated FGFR1 (p-Y766) inside 362 
the cells. (C) Orthogonal view of Z-stack image of meningococcal colonies on the apical surface 363 
(arrows) of the cells which only recruited activated FGFR1 (p-Y766, Green) and internalized 364 
colonies colocalizing with in α-actinin (pY766). (D) Infected HBMECs probed for activated FGFR1 365 
(p-Y766) and Rab5 (sc-46692) showing bacteria co-localised with both molecules. 366 
 367 
Figure 3. FGFR1 down regulation plays an important role in invasion of meningococci 368 
into HBMECs. (A) HBMECs were infected with Nm MC58 for 4h (MOI: 10). Cells were washed 369 
and lysed in 500 µl of 1% saponin in PBS and 100 µl of homogenized lysates used for serial 370 
dilution preparation. 10 µl of each dilution was plated onto chocolate agar and CFUs were 371 
calculated for each sample. There was a significant reduction in the number of meningococci 372 
associated with HMBECs after FGFR1 knockdown (FGFR1 siRNA; p=0.0031, two-tailed unpaired 373 
t-test, n=8). Experiments were performed in triplicate wells and means shown represent 8 374 
independent experiments. (B) For invasion assays, gentamicin was added after 4h of infection 375 
and plates were incubated for a further 1h. Cells were then washed, lysed, homogenised and 376 
dilutions plated onto chocolate blood agar plates. There was a significant difference between 377 
the number of internalised meningococci in untreated cells compared to HBMECs transfected 378 
with FGFR1 siRNA (p=0.0003, two-tailed t-test, n=7). Error bars represent standard deviation 379 
of mean. 380 
  381 
 
Figure 4. N. meningitidis and N. gonorrhoeae interact directly with the extracellular 382 
domain of FGFR1. Fc-tagged purified proteins were used as the immobilised ligand in ELISA 383 
experiments. Levels of interaction with DIG-labelled bacteria were measured; the values 384 
shown are those following subtraction of binding to 1% BSA/PBS. (A) N. meningitidis MC58 385 
interacts directly with the extracellular domain of Fc-FGFR1 (two tailed t-test; each 386 
experiment was performed in 6 technical replicates and the data shown is derived from 6 387 
independent experiments). (B) Binding of commensal Neisseria, but not N. gonorrhoeae, to 388 
FGFR1 IIIc was significantly lower than that shown by Nm MC58. (C) Clinical isolates of 389 
serogroups A, B and C of N. meningitidis, display similar binding levels to FGFR1 IIIC, when 390 
compared to MC58. (D) The meningeal pathogens H. influenzae and S. pneumoniae bound 391 
FGFR1 IIIc to a negligible degree that was significantly lower than cells of Nm MC58 392 
(p≤0.002).  393 
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Additional images for review
Figure R1. Images of uninfected HBMECs, and the localization patterns of 37LRP and 67LR in regards to 
FGFR1. We found no cross reactivity of secondary antibodies against 37LRP and 67LR with FGFR1 













HBMEC apical surfaceHBMEC membraneHBMEC cytoplasm
Figure R2. MC58 cells recruit activated FGFR1 (p-Y766 in green) on apical surface of the cells and 
internalised bacterial cell are co-localized with ⍺-actinin in cytoplasm. 
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